Page last updated: 2024-09-05

technetium tc 99m pentetate and Ureteral Neoplasms

technetium tc 99m pentetate has been researched along with Ureteral Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kan, Y; Liu, J; Wang, W; Yang, J; Yuan, L1
Fujii, Y; Ishikawa, Y; Ishioka, J; Kawano, K; Kihara, K; Matsuoka, Y; Morimoto, S; Saito, K; Waseda, Y; Yokoyama, M1

Other Studies

2 other study(ies) available for technetium tc 99m pentetate and Ureteral Neoplasms

ArticleYear
Right Ureteral Carcinoma Suggested by 99mTc-DTPA Renography in a Patient With Left Pyelocaliceal Carcinoma.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:7

    Topics: Aged; Carcinoma, Papillary; Female; Humans; Radioisotope Renography; Radiopharmaceuticals; Technetium Tc 99m Pentetate; Ureteral Neoplasms

2018
Predictive ability of renal cortex enhancement in dynamic computed tomography for residual renal function after nephroureterectomy: Comparison with
    International journal of urology : official journal of the Japanese Urological Association, 2019, Volume: 26, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Female; Glomerular Filtration Rate; Humans; Kidney Cortex; Kidney Neoplasms; Male; Models, Biological; Nephroureterectomy; Patient Selection; Postoperative Period; Predictive Value of Tests; Radioisotope Renography; Retrospective Studies; Technetium Tc 99m Pentetate; Tomography, X-Ray Computed; Ureteral Neoplasms

2019